Immunome, Inc. ( IMNM) - Stock Earnings
IMNM Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -57.5 million USD | — USD |
| 2025Q4 | -69.9 million USD | — USD |
| 2026Q1 | -53.8 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
IMNM Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -106.8 million USD | 14.0 million USD |
| 2024 | -293.0 million USD | 9.0 million USD |
| 2025 | -212.4 million USD | 6.9 million USD |
| 2026 Est. | — | — |
IMNM
Price: $18.07
52 week price:
Earnings Per Share: -2.39 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 8759
Market Capitalization: 1.9 billion